The FDA should develop a new regulatory framework to replace the 510(k) clearance process for moderate-risk medical devices, advises a report issued July 29 by the Institute of Medicine.

The FDA's new Medical Device Innovation Initiative aims to facilitate the development and evaluation of new medical devices; strengthen the nation’s research infrastructure; and respond quickly to scientific breakthroughs.